- ►annals.org [PDF] JA Heit, CG Elliott, AA Trowbridge, BF Morrey, … - Annals of internal medicine, 2000 - Am Coll Physicians John A. Heit, MD; C. Gregory Elliott, MD; Arthur A. Trowbridge, MD; Bernard F.
Morrey, MD; Michael Gent, DSc; and Jack Hirsh, MD, for the Ardeparin
Arthroplasty Study Group* ... Background: The optimal duration of ... Cited by 73 - Related articles - All 5 versions
MR Lassen, LC Borris, BS Anderson, HP Jensen … - Thrombosis research, 1998 - ncbi.nlm.nih.gov The aim of this study was to compare the efficacy and safety of prolonged (35
days) thromboprophylaxis with a standard length (7 days) regimen of a low
molecular weight heparin in patients undergoing total hip arthroplasty. The ... Cited by 133 - Related articles - BL Direct - All 3 versions
JS Ginsberg, M Gent, F Turkstra, HR Buller, B … - Archives of Internal Medicine, 2000 - archinte.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 72 - Related articles - BL Direct - All 4 versions
JR Leclerc, M Gent, J Hirsh, WH Geerts, JS … - Archives of Internal Medicine, 1998 - archinte.highwire.org Methods We studied a cohort of 1984 consecutive patients who had hip or knee
arthroplasty at 1 of 28 participating hospitals. Patients received enoxaparin
prophylaxis, 30 mg subcutaneously every 12 hours for up to 14 days, and ... Cited by 109 - Related articles - BL Direct - All 4 versions
RD Hull, GF Pineo, C Francis, D Bergqvist, C … - Archives of Internal Medicine, 2000 - archinte.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 141 - Related articles - BL Direct - All 5 versions
- ►ejbjs.org CW COLWELL, DK COLLIS, R Paulson, J … - The Journal of Bone and Joint Surgery, 1999 - JBJS Background: Venous thromboembolic disease in the form of deep venous thrombosis
and pulmonary embolism is a major risk after a total hip arthroplasty.
Enoxaparin, a low-molecular-weight heparin, has been shown to reduce the ... Cited by 184 - Related articles - BL Direct - All 7 versions
- ►jbjs.org [PDF] PC Comp, TE Spiro, RJ Friedman, TL … - The Journal of Bone and Joint Surgery, 2001 - JBJS Theodore E. Spiro, MD Cardiovascular Therapeutic Area, European Operations Site,
E2/309, Aventis Pharma, 20 Avenue Raymond Aron, 92160 Antony, France. E-mail
address: theodore.spiro@aventis.com. Please address correspondence and ... Cited by 101 - Related articles - BL Direct - All 5 versions
OE Dahl, G Andreassen, T Aspelin, C Muller, … - Thrombosis and haemostasis, 1997 - schattauer.de Table 1 Patients with adverse events who were withdrawn from the study between
days 7 and 35 Adverse Events (AE) Dalteparin Placebo Total patient no. Luxation
of prothesis 2 4 6 Gastro-intestinal disorder 1 1 2 Death (PE) 0 1 1 ... Cited by 227 - Related articles - BL Direct - All 3 versions
D Manganelli, M Pazzagli, D Mazzantini, G … - Respiration, 2000 - content.karger.com The aim of this study was to assess the incidence of deep vein thrombosis (DVT)
and pulmonary embolism (PE) until 45 days after elective total hip replacement
(THR) and the efficacy of prolonged unfractioned heparin (UH) prophylaxis ... Cited by 17 - Related articles - BL Direct - All 5 versions
JA Caprini, JI Arcelus, G Motykie, JC Kudrna … - Journal of Vascular Surgery, 1999 - Elsevier The purpose of this study was to assess with venous duplex scanning (VDS) the
rate of DVT at 1 and 4 weeks after THR in a group of patients who underwent a
combined therapy of warfarin and physical methods for 1 month after surgery. Cited by 21 - Related articles - BL Direct - All 7 versions
